McCormick beats quarterly sales estimates on steady demand
18 hours ago
McCormick surpassed third-quarter sales estimates at $2.02 billion, lifting shares 5% due to robust demand for affordable condiments linked to GLP-1 drug trends. The firm maintains confidence in its planned $65 billion merger with Unilever's foods division.